DK1448207T3 - Doseringsplan og farmaceutisk sammensætning af nödprævention - Google Patents

Doseringsplan og farmaceutisk sammensætning af nödprævention

Info

Publication number
DK1448207T3
DK1448207T3 DK02783334T DK02783334T DK1448207T3 DK 1448207 T3 DK1448207 T3 DK 1448207T3 DK 02783334 T DK02783334 T DK 02783334T DK 02783334 T DK02783334 T DK 02783334T DK 1448207 T3 DK1448207 T3 DK 1448207T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
dosage schedule
emergency contraception
contraception
emergency
Prior art date
Application number
DK02783334T
Other languages
Danish (da)
English (en)
Inventor
Look Paul F A Van
Illesne Balogh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of DK1448207T3 publication Critical patent/DK1448207T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK02783334T 2001-11-27 2002-11-26 Doseringsplan og farmaceutisk sammensætning af nödprævention DK1448207T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
EP02783334A EP1448207B1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (1)

Publication Number Publication Date
DK1448207T3 true DK1448207T3 (da) 2005-06-27

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02783334T DK1448207T3 (da) 2001-11-27 2002-11-26 Doseringsplan og farmaceutisk sammensætning af nödprævention

Country Status (33)

Country Link
US (1) US20050288264A2 (enExample)
EP (1) EP1448207B1 (enExample)
JP (1) JP2005516904A (enExample)
KR (1) KR100908161B1 (enExample)
CN (1) CN1551774A (enExample)
AP (1) AP1849A (enExample)
AT (1) ATE293978T1 (enExample)
AU (1) AU2002347401A1 (enExample)
BR (1) BR0210595A (enExample)
CA (1) CA2450359C (enExample)
DE (1) DE60203929T2 (enExample)
DK (1) DK1448207T3 (enExample)
EA (1) EA006545B1 (enExample)
EC (1) ECSP045171A (enExample)
ES (1) ES2239727T3 (enExample)
GE (1) GEP20063882B (enExample)
HR (1) HRP20040584B1 (enExample)
HU (1) HU227198B1 (enExample)
IL (1) IL159394A0 (enExample)
IS (1) IS2691B (enExample)
MA (1) MA27076A1 (enExample)
MX (1) MXPA04005104A (enExample)
NO (1) NO333984B1 (enExample)
NZ (1) NZ530056A (enExample)
OA (1) OA12730A (enExample)
PL (1) PL206010B1 (enExample)
PT (1) PT1448207E (enExample)
RS (1) RS50768B (enExample)
SI (1) SI1448207T1 (enExample)
TN (1) TNSN04048A1 (enExample)
UA (1) UA79942C2 (enExample)
WO (1) WO2003045397A1 (enExample)
ZA (1) ZA200404114B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465907C2 (ru) * 2006-12-20 2012-11-10 Тева Вимен'С Хелс, Инк. Распадающиеся в полости рта твердые дозированные формы, содержащие прогестин, и способы получения и применение указанных дозированных форм
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP2365811A1 (en) * 2008-12-12 2011-09-21 Laboratoire HRA Pharma A method for contraception
WO2010119029A1 (en) 2009-04-14 2010-10-21 Laboratoire Hra-Pharma Method for on-demand contraception
CN102458386B (zh) 2009-06-23 2016-04-06 拜耳知识产权有限责任公司 用于紧急避孕的药物组合物
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
RS54880B1 (sr) 2011-06-01 2016-10-31 Estetra Sprl Postupak proizvodnje intermedijarnih proizvoda estetrola
ME02585B (me) 2011-06-01 2017-06-20 Estetra Sprl Postupak proizvodnje intermedijara estetrola
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
CA2843951C (en) * 2011-08-11 2019-08-06 Wout WOUTERS Use of estetrol as emergency contraceptive
SG11201503275RA (en) 2012-11-22 2015-06-29 Bayer Pharma AG Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
CN105451737B (zh) 2013-05-23 2018-04-10 拜耳医药股份有限公司 药物组合物及其用途以及所述药物组合物用于按需避孕的施用方法
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Also Published As

Publication number Publication date
TNSN04048A1 (en) 2006-06-01
KR100908161B1 (ko) 2009-07-16
EA200400731A1 (ru) 2004-12-30
WO2003045397A1 (en) 2003-06-05
CA2450359C (en) 2011-05-10
JP2005516904A (ja) 2005-06-09
ECSP045171A (es) 2004-08-27
AP2004003046A0 (en) 2004-06-30
ATE293978T1 (de) 2005-05-15
EP1448207B1 (en) 2005-04-27
ZA200404114B (en) 2005-10-26
HU227198B1 (en) 2010-10-28
MA27076A1 (fr) 2004-12-20
EP1448207A1 (en) 2004-08-25
NZ530056A (en) 2005-02-25
PL369520A1 (en) 2005-04-18
BR0210595A (pt) 2004-06-08
RS4204A (sr) 2007-02-05
OA12730A (fr) 2006-06-28
SI1448207T1 (en) 2005-10-31
PL206010B1 (pl) 2010-06-30
UA79942C2 (en) 2007-08-10
NO333984B1 (no) 2013-11-04
US20050288264A2 (en) 2005-12-29
HUP0105173D0 (en) 2002-02-28
EA006545B1 (ru) 2006-02-24
MXPA04005104A (es) 2004-08-19
HRP20040584A2 (en) 2005-02-28
KR20040066088A (ko) 2004-07-23
DE60203929D1 (de) 2005-06-02
IS7065A (is) 2003-12-05
NO20041607L (no) 2004-04-20
IL159394A0 (en) 2004-06-01
HRP20040584B1 (en) 2012-11-30
RS50768B (sr) 2010-08-31
AU2002347401A1 (en) 2003-06-10
DE60203929T2 (de) 2006-01-19
AP1849A (en) 2008-05-23
HUP0105173A2 (hu) 2003-08-28
GEP20063882B (en) 2006-07-25
US20050032755A1 (en) 2005-02-10
HUP0105173A3 (en) 2004-03-29
CN1551774A (zh) 2004-12-01
CA2450359A1 (en) 2003-06-05
IS2691B (is) 2010-10-15
PT1448207E (pt) 2005-08-31
ES2239727T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
DK1562556T3 (da) Farmaceutiske sammensætninger og doseringsformer af thalidomid
IS2691B (is) Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð
ATE296619T1 (de) Feste orale dosierungsform von simethicon
BRPI0209720A2 (pt) dosagem e embalagem de medicação com liberação controlada
DE60121992D1 (de) Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
FI20011478L (fi) Farmaseuttinen koostumus
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
PL368519A1 (pl) Kompozycje farmaceutyczne amlodypiny i atorwastatyny
HUP0401656A3 (en) Mch antagonists for the treatment of obesity and pharmaceutical compositions containing them
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
NO20033123L (no) Terapeutisk hinne dannende sammensetning og behandlingsplan derav
GB0108470D0 (en) Pharmaceutical compositions and their use
FI20022128A0 (fi) Farmaseuttinen koostumus
DK2017269T3 (da) Krystallinsk form II af ritonavirindeholdende farmaceutisk sammensætning og fremstilling heraf
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
DE60329614D1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
DE60232445D1 (de) Cetirizin und pseudoephedrin enthaltende tablette
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
NO20034172L (no) Bisykliske guanidinderivater og terapeutiske anvendelser derav
DE60109730D1 (de) Zementzusatzmittel und Zementzusammensetzung
DK1385513T3 (da) Farmaceutiske kombinationer af pyridoindollonderivater og anticancermidler
DK1406591T3 (da) Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron
EP1413314A4 (en) MEDICAL COMPOSITIONS